T-cell recognition of oncogene products: a new strategy for immunotherapy.
Ioannides
C G
CG
Department of Gynecology, University of Texas M. D. Anderson Cancer Center, Houston.
Ioannides
M G
MG
O'Brian
C A
CA
D000595:Amino Acid Sequence; D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics; D003198:Computer Simulation; D000939:Epitopes / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000209:etiology / Q000628:therapy*; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000276:immunology; D051381:Rats; D018719:Erb-b2 Receptor Tyrosine Kinases; D017385:Sequence Homology; D013601:T-Lymphocytes / Q000276:immunology*
D000951:Antigens, Neoplasm; D000939:Epitopes; D066246:ErbB Receptors; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases